Do you want to read an article? Please log in or register.
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
Further Publications
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)